openPR Logo
Press release

Transfemoral Compression Devices Market Research Report and Forecast up to 2024

06-15-2017 06:52 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: TMR

Transfemoral Compression Devices Market Research Report

Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy in comparison with manual compression has been observed. The first method used for closing the holes in the femoral artery was the use of manual compression. As the holes got bigger, constraints on physicians increased due to rising complications. The increase in complication has resulted in technological innovation and led to the use of transfemoral approach.

The transfemoral approach is commonly used to obtain arterial access during coronary angiography and amputation procedures. Hemostasis is usually performed through manual compression after removal of sheath. Vascular access site complications arise due to insignificant morbidity which occur after coronary interventional procedures. The percentage of these complications is about 0.5% to 16.8% of procedures performed. The rate of complications depend on the physician experience, the type of intervention applied, and introducer size
.
View Report @ http://www.transparencymarketresearch.com/transfemoral-compression-devices-market.html

Transfemoral products such as shrinkers are used for above the knee (AKA) and below the knee amputees (BKA). These products are available in wide variety of materials with different compression gradient. These transfemoral devices are prescribed by physician after two to three days of post operation. These devices help to reshape the limb after amputation procedure by increasing the blood flow and reducing the fluid retention in the surrounding area of the amputee’s limb. These transfemoral devices are generally used in hospitals, ambulatory surgical centers, and specialty clinics.
Increasing awareness and benefits related to transfemoral devices in terms of reduction in occurrence of complications and increased efficiency is expected to drive the transfemoral compression devices market during the forecast period. Transfemoral compression devices are the first choice in a number of cardiac catheterization labs across the world, as these provide increased comfort to patients.

Studies have shown that these transfemoral devices have reduced the procedure cost considerably when compared to the femoral compression devices in terms of procedure and hemostasis time and cost of repeating catheterization.
Major drivers of the transfemoral compression devices market are increase in obese population, rise in incidence of chronic diseases, growing awareness, increase in health care expenditure, and technological advancement. The total cost of device, stringent regulatory scenarios, and lack of skilled surgeons are the major restraints of the market. Increased risk of infection during the procedure is likely to hamper the growth of the transfemoral compression devices market during the forecast period. According to the American Academy of Orthopedic Surgeons, the number of arthroplasty surgeries to be conducted in the U.S. by 2030 will reach approximately to 3 million. Therefore, considering the rise in number of procedures in the U.S. alone, the incidence of orthopedic conditions globally shall also increase at a rapid pace creating opportunities in the transfemoral compression devices market.

Geographically, the global transfemoral compression devices market has been segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the global transfemoral compression devices market largely because of increasing population, rising number of neurological surgeries, and technological advancements. North America was closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for transfemoral compression devices because of increasing health care expenditure in the region and rising demand.

Key players in the global trans-femoral compression devices market are Abbot Laboratories, 3M Health Care, Paul Hartman AG, BSN medical, Merit Medical Systems, Inc., Vascular Perspectives Ltd., Terumo Corporation, Vascular Solutions, Inc., and TZ Medical, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Get accurate market forecast and analysis on the Transfemoral Compression Devices Market Request a sample to stay abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20948

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transfemoral Compression Devices Market Research Report and Forecast up to 2024 here

News-ID: 581503 • Views: 471

More Releases from TMR

01-24-2020 | Health & Medicine
TMR
Myasthenia Gravis Market : Insights and Emerging Trends by 2025
Healthcare scientists, researchers, and practitioners are under constantly pressure to reinvent current medical practices to improve treatment and diagnosis. This factor has always kept the medical fraternity on its toes, and has often led to improvements in generic treatment mechanisms for common diseases and disorder. Healthcare resource utilization studies suggest the US Healthcare industry is majorly affected by the heavy incidence of refractory myasthenia gravis. Not only does the high
01-24-2020 | Health & Medicine
TMR
Chronic Myelogenous Leukemia Treatment Market : Trends Research and Projections …
The demand within the global market for chronic myelogenous leukaemia treatment has been rising on account of advancements in the worldwide healthcare sector. The presence of a robust domain for cancer treatment is expected to improve the chances of market growth. The vendors operating in the global chronic myelogenous leukaemia treatment have made concerted efforts to improve their revenue index. The relation of the global chronic myelogenous leukaemia treatment market
01-24-2020 | Health & Medicine
TMR
Sexually Transmitted Diseases (STDs) Drug Market : Research and Analyzed Report …
Transparency Market Research (TMR) observes, the global sexually transmitted diseases (STDs) drug market is highly competitive due to presence of several strong players. The key players are investing on the research and development activities for developing a novel drugs in order to be a part of competition. Some of the key players in the global sexually transmitted diseases drug market includes Pfizer INC, Bayer Healthcare, Hoffmann La Roche, Eli Lilly,
01-24-2020 | Health & Medicine
TMR
Plasma Protease C1-inhibitor Treatment Market : Growth Analysis, Trends and Scop …
The vendor landscape of the global market for plasma protease c1-inhibitor treatment market is largely consolidated with a handful of companies collectively accounting for a lion's share in the market and maintaining a tough level of competition, observes Transparency Market Research in a recent report. The company Shire plc. held the dominant spot in the market, thanks to its expansive product portfolio and extensive geographical reach. Other leading companies in

All 5 Releases


More Releases for Transfemoral

Transfemoral Compression Devices Market Latest Report with Forecast to 2024
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy
Transfemoral Compression Devices Market Volume Forecast and Value Chain Analysis …
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy
Transfemoral Compression Devices Market 2024: Overview, Opportunities, In-Depth …
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy
Transfemoral Compression Devices Market Scope and Trends Report 2024
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy
Transfemoral Compression Devices Market Research Report Forecast to 2024
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy
Transfemoral Compression Devices Market Research Report by Geographical Analysis …
Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy